Leonard Reyno

2.3k total citations
46 papers, 1.6k citations indexed

About

Leonard Reyno is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonard Reyno has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonard Reyno's work include Prostate Cancer Treatment and Research (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Leonard Reyno is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Palliative Care and End-of-Life Issues (4 papers). Leonard Reyno collaborates with scholars based in United States, Canada and France. Leonard Reyno's co-authors include Mario A. Eisenberger, Merrill J. Egorin, Victoria J. Sinibaldi, Malcolm J. Moore, Peter Venner, Eric Winquist, Timothy J. Whelan, R. Sridhara, D. Scott Ernst and K.N. Chi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Leonard Reyno

46 papers receiving 1.5k citations

Peers

Countries citing papers authored by Leonard Reyno

Since Specialization

Citations

This map shows the geographic impact of Leonard Reyno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Reyno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Reyno more than expected).

Fields of papers citing papers by Leonard Reyno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Reyno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Reyno. The network helps show where Leonard Reyno may publish in the future.

Co-authorship network of co-authors of Leonard Reyno

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Reyno. A scholar is included among the top collaborators of Leonard Reyno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Reyno. Leonard Reyno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	612O Preliminary results from a phase I study of CFT1946, a novel BIDAC degrader in mutant BRAF V600 solid tumors 2024 ·Annals of Oncology ·María Vieito, (unknown), (unknown), Ezra Y. Rosen, Jordi Rodón, Víctor Moreno, Valentina Gambardella, (unknown), Sophie Cousin, Philippe A. Cassier, (unknown), (unknown), (unknown), (unknown), (unknown), Riadh Lobbardi, Hao Liu, Eunju Hurh, Leonard Reyno, Elizabeth I. Buchbinder	3
2	126P Evaluation of myeloid targeting agents, PY159 and PY314, in two dose expansion phase Ib trials in platinum-resistant ovarian cancer 2023 ·Immuno-Oncology Technology ·Oladapo Yeku, Minal Barve, (unknown), (unknown), Amita Patnaik, Patricia LoRusso, (unknown), Afshin Dowlati, Siqing Fu, Michael S. Gordon, Joleen M. Hubbard, Shivaani Kummar, Christos E. Kyriakopoulos, Erin L. Schenk, (unknown), Linda Liang, Yuan Li, Leonard Reyno, Marc C. Chamberlain, Ira Winer	2
3	Tuning the Tumor Myeloid Microenvironment to Fight Cancer 2019 ·Frontiers in Immunology ·Nadine S. Jahchan, Adriana M. Mujal, Joshua L. Pollack, Mikhail Binnewies, Venkataraman Sriram, Leonard Reyno, Matthew F. Krummel	91
4	A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer 2019 ·Investigational New Drugs ·Deaglan Joseph McHugh, Mario A. Eisenberger, Elisabeth I. Heath, Justine Y. Bruce, Daniel C. Danila, Dana E. Rathkopf, Jarett L. Feldman, Susan F. Slovin, Banmeet S. Anand, Rong Chu, (unknown), Leonard Reyno, Emmanuel S. Antonarakis, Michael J. Morris	19
5	Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas 2018 ·Clinical Cancer Research ·John A. Thompson, Robert J. Motzer, Ana M. Molina, Toni K. Choueiri, Elisabeth I. Heath, Bruce G. Redman, Randeep Sangha, D. Scott Ernst, Роберто Пили, Stella K. Kim, Leonard Reyno, (unknown), Fabio Trave, Banmeet S. Anand, Karen Morrison, Fernando Doñate, Christian Kollmannsberger	48
6	Phase I studies of anti-ENPP3 antibody drug conjugates (ADCs) in advanced refractory renal cell carcinomas (RRCC). 2015 ·Journal of Clinical Oncology ·John A. Thompson, Robert J. Motzer, Ana M. Molina, Toni K. Choueiri, Elisabeth I. Heath, Christian Kollmannsberger, Bruce G. Redman, Randeep Sangha, D. Scott Ernst, Роберто Пили, Anna Butturini, (unknown), Fabio Trave, Banmeet S. Anand, Yao Huang, Leonard Reyno	22
7	Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer 2013 ·Annals of Oncology ·Brian M. Wolpin, Eileen M. O’Reilly, Yoo-Joung Ko, Lawrence S. Blaszkowsky, Mark U. Rarick, Caio Rocha‐Lima, Paul S. Ritch, Emily Chan, Jennifer L. Spratlin, Teresa Macarulla, Elaine McWhirter, Denis Pezet, Mikhail Lichinitser, Laslo Roman, Alan C. Hartford, Kendall Morrison, (unknown), M. Vincent, Leonard Reyno, Manuel Hidalgo	29
8	Phase I Trial of Asg-5me in Metastatic Castration Resistant Prostate Cancer (CRPC) 2012 ·Annals of Oncology ·Michael J. Morris, Justine Y. Bruce, Leonard Reyno, (unknown), Alan C. Hartford, (unknown), (unknown), Mario A. Eisenberger	1
9	Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19 2006 ·Breast Cancer Research and Treatment ·Jianhua Liu, Dongsheng Tu, Janet Dancey, Leonard Reyno, Kathleen I. Pritchard, Joseph L. Pater, Lesley Seymour	30
10	The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients 2004 ·Supportive Care in Cancer ·Dauna Crooks, Timothy J. Whelan, Leonard Reyno, Andy Willan, Richard Tozer, (unknown), Jim Miller, Michelle Tew, Paul Elliott, Mark N. Levine	21
11	Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer 2003 ·JNCI Journal of the National Cancer Institute ·Timothy J. Whelan, Carol Sawka, Mark Levine, Amiram Gafni, Leonard Reyno, Andrew R. Willan, Jacob Julian, Susan Dent, Hakam Abu-Zahra, E. Chouinard, Richard Tozer, K. Pritchard, (unknown)	185
12	The Multidimensional Pain Inventory profiles in patients with chronic cancer-related pain: an examination of generalizability 2000 ·Pain ·Christine Zaza, Leonard Reyno, Dwight E. Moulin	20
13	A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study 2000 ·Annals of Oncology ·Wilson H. Miller, Leonard Reyno, Gordon Loewen, S. Huan, Eric Winquist, Malcolm J. Moore, Andrew C.B. Cato, (unknown), J A Truglia, S. Matthews, Janet Dancey, Elizabeth A. Eisenhauer	12
14	Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer 1999 ·Patient Education and Counseling ·(unknown), (unknown), Timothy J. Whelan, Leonard Reyno, (unknown)	23
15	Effects of storage on the binding of carboplatin to plasma proteins 1995 ·Cancer Chemotherapy and Pharmacology ·Kadir Erkmen, Merrill J. Egorin, Leonard Reyno, Robert D. Morgan, James H. Doroshow	28
16	Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. 1995 ·Journal of Clinical Oncology ·Mario A. Eisenberger, Victoria J. Sinibaldi, Leonard Reyno, R. Sridhara, Duncan I. Jodrell, Eleanor G. Zuhowski, Katherine H. R. Tkaczuk, Mark H. Lowitt, Ramzi K. Hemady, S. Jacobs	66
17	Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer. 1994 ·Journal of Clinical Oncology ·Duncan I. Jodrell, Leonard Reyno, R. Sridhara, Mario A. Eisenberger, Katherine H. R. Tkaczuk, Eleanor G. Zuhowski, Victoria J. Sinibaldi, Matjaž Novak, Merrill J. Egorin	42
18	Suramin 1994 ·Cancer Treatment Reviews ·Mario A. Eisenberger, Leonard Reyno	25
19	Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer 1993 ·European Journal of Cancer ·Leonard Reyno, Mark N. Levine, Peter Skingley, Andrew Arnold, (unknown)	49
20	Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer. 1993 ·Journal of Clinical Oncology ·Leonard Reyno, Merrill J. Egorin, Renzo Canetta, Duncan I. Jodrell, K. Swenerton, J Pater, James N. Burroughs, Matjaž Novak, R. Sridhara	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact